Concerto HealthAI during the J.P. Morgan Healthcare Conference announced it had secured $150 million in a new round of funding and launched two real-world data collaborations with pharmaceutical companies, FierceBiotech reports.
Concerto also debuted its new real-world data platform, eurekaHealth 3.0, which uses artificial intelligence (AI) to forecast the characteristics of a patient population, according to the report.
Concerto also discussed partnerships with Pfizer and Janssen.
“We are excited to bring our unique integration of RWD, technology applications, and data science expertise to collaborate with Janssen’s researchers and data scientists to optimize drug development for patients,” said Concerto CEO Jeff Elton.
To read the full report on FierceBiotech, click here.